We're committed to a clean and safe facility. Submit your health declaration
Guntur,Andhra Pradesh,India
BLADDER CANCER
Q: What is bladder cancer?
A: Bladder cancer is a type of cancer that starts in the cells lining the bladder, a hollow organ in the pelvis that stores urine. The most common type of bladder cancer is urothelial carcinoma, which begins in the urothelial cells that line the bladder.
Q: What are the risk factors for bladder cancer?
A: The main risk factors include:
-
Tobacco smoking: Smoking is the most significant risk factor, contributing to around half of all bladder cancer cases.
-
Exposure to chemicals: Certain workplace chemicals, including those used in the dye, rubber, leather, and paint industries, can increase the risk.
-
Ionizing radiation: Exposure to radiation from previous cancer treatments may also contribute to risk.
-
Chronic urinary infections: Recurrent bladder infections or bladder stones can raise the risk.
-
Age and gender: Bladder cancer is more common in older adults, particularly in men.
-
Family history: A family history of bladder cancer may also increase your risk.
Q: What are the signs of bladder cancer?
A: Symptoms of bladder cancer include:
-
Blood in the urine (hematuria): Often the most noticeable symptom, and may appear without pain.
-
Frequent urination or feeling the need to urinate suddenly.
-
Painful urination (dysuria).
-
Lower back pain or pain in the lower abdomen.
-
Weight loss or fatigue can occur in advanced stages.
If you experience any of these symptoms, it is important to consult a healthcare provider for further investigation.
Q: How is bladder cancer diagnosed?
A: The main diagnostic methods include:
-
Cystoscopy: A procedure where a thin tube with a camera is inserted through the urethra into the bladder to look for abnormalities.
-
Biopsy: During a cystoscopy, a small sample of tissue may be taken from any suspicious areas to confirm the presence of cancer.
-
Imaging tests: CT scans or MRI are often used to assess the extent of cancer spread.
-
Urinary markers: Tests that detect cancer-related proteins in the urine may also be used in some cases.
Q: What are the different stages of bladder cancer?
A: Bladder cancer is classified by how deeply it has invaded the bladder:
-
Non-muscle-invasive bladder cancer (NMIBC): Cancer is confined to the inner lining of the bladder.
-
Muscle-invasive bladder cancer (MIBC): Cancer has spread into the bladder’s muscle layer.
-
Advanced/metastatic bladder cancer: Cancer has spread beyond the bladder to other parts of the body, such as the lymph nodes, liver, or bones.
Q: What are the treatment options for non-muscle-invasive bladder cancer (NMIBC)?
A: Treatment options for NMIBC typically include:
-
Transurethral resection of the bladder tumor (TURBT): A surgical procedure to remove tumors from the bladder.
-
Intravesical chemotherapy: After TURBT, patients may receive chemotherapy directly into the bladder to reduce the risk of recurrence.
-
BCG therapy: Patients at higher risk of recurrence may receive bacillus Calmette-Guerin (BCG) therapy, which is an immunotherapy that stimulates the immune system to fight cancer.
Q: What treatments are used for muscle-invasive bladder cancer (MIBC)?
A: Treatment for MIBC generally includes:
-
Radical cystectomy: Removal of the bladder.
-
Neoadjuvant chemotherapy: Chemotherapy is often given before surgery to shrink the tumor.
-
Adjuvant therapy: Chemotherapy or immunotherapy after surgery may be recommended depending on individual factors.
Q: What treatments are used for advanced/metastatic bladder cancer?
A: For advanced or metastatic bladder cancer, treatment may include:
-
Chemotherapy: The first-line treatment for metastatic bladder cancer.
-
Immunotherapy: Medications like pembrolizumab or nivolumab are used to stimulate the immune system to target cancer cells, especially if the cancer is PD-L1 positive.
-
Targeted therapy: Patients with mutations in the FGFR gene may benefit from targeted therapies that focus on this genetic alteration.
Q: How will bladder cancer treatment affect my daily life?
A: Bladder cancer treatments, particularly surgery like radical cystectomy, can have significant effects on your life:
-
Urine diversion: After a radical cystectomy, patients may need to use a stoma (a surgically created opening) to pass urine.
-
Emotional effects: The changes in bodily function and appearance can affect self-esteem and emotional well-being. Support from family, friends, or a therapist can help.
-
Sexual health: There may be an impact on sexual function, and counseling may help address these issues.
-
Dietary adjustments: A dietitian may assist in managing nutrition, especially if there are challenges with urinary diversion or altered eating habits.
​
Q: How often will I need follow-up care after treatment for bladder cancer?
A: Follow-up appointments are important to monitor for recurrence. These may include:
-
Regular cystoscopy to check the bladder for new tumors.
-
Imaging tests (such as CT or MRI) to detect cancer spread.
-
Blood tests to monitor kidney and bladder health.
The frequency of follow-up appointments varies but usually occurs every 3–6 months during the first two years after treatment.
Q: Does bladder cancer recur?
A: Yes, bladder cancer can recur, especially if it was not fully removed or if it was a more aggressive form. Regular follow-ups are essential for detecting any recurrence early. Treatment for recurrence may involve more surgery, chemotherapy, or immunotherapy.
Q: How can I lower my risk of developing bladder cancer?
A: You can reduce your risk by:
-
Quitting smoking and avoiding exposure to tobacco smoke.
-
Avoiding exposure to harmful chemicals at work (e.g., in the dye, rubber, and paint industries).
-
Staying hydrated and urinating frequently to flush out harmful substances from the bladder.
-
Managing urinary infections and seeking treatment for chronic conditions like bladder stones or chronic cystitis.
​PROSTATE CANCER​​
Q: What is prostate cancer?
A: Prostate cancer is a type of cancer that begins in the prostate gland, which is a small organ in men that produces seminal fluid. Many prostate cancers grow slowly and may not spread, but some can grow more aggressively.
Q: What are the risk factors for prostate cancer?
A: While the exact cause is not known, several factors may increase the risk of developing prostate cancer:
-
Age: Prostate cancer is more common in older men, especially those over 70 years old.
-
Family history: Men with a family history of prostate cancer are at a higher risk.
-
Race: African-American men are at a higher risk compared to other racial groups.
-
Genetics: Inherited gene mutations, such as in BRCA1 or BRCA2, may increase risk.
-
Diet: A diet high in red meat and low in fruits and vegetables may contribute to a higher risk.
Q: What are the signs and symptoms of prostate cancer?
A: In its early stages, prostate cancer often doesn’t show symptoms. However, as the cancer progresses, symptoms may include:
-
Frequent urination, especially at night.
-
Difficulty urinating or a weak urine stream.
-
Pain or burning sensation while urinating.
-
Blood in the urine or semen.
-
Pain in the lower back, hips, or pelvis.
If you notice any of these symptoms, it is important to consult a healthcare provider for further evaluation.
Q: How is prostate cancer diagnosed?
A: Prostate cancer is diagnosed through:
-
Prostate-specific antigen (PSA) test: A blood test that measures the level of PSA, a protein produced by the prostate. Elevated levels may indicate prostate cancer, though other conditions can cause high PSA levels.
-
Digital rectal exam (DRE): A clinical exam where the doctor checks the prostate for lumps or abnormal texture.
-
MRI scans: To help identify the location and extent of the cancer.
-
Biopsy: If cancer is suspected, a biopsy is done to confirm the diagnosis by taking a small tissue sample from the prostate.
Further tests, such as bone scans or CT scans, may be used to check if cancer has spread to other parts of the body.
Q: How is prostate cancer staged?
A: Prostate cancer is staged based on the size of the tumor, whether it has spread to the lymph nodes, and if it has spread to other parts of the body, such as bones. The stages are:
-
Stage I: The cancer is confined to the prostate and is usually small and not detectable by DRE or imaging.
-
Stage II: The tumor is confined to the prostate but is larger.
-
Stage III: The cancer has spread beyond the prostate to nearby tissues or lymph nodes.
-
Stage IV: The cancer has spread to distant parts of the body, such as bones or organs.
Q: What are the treatment options for prostate cancer?
A: Treatment for prostate cancer depends on the stage and aggressiveness of the cancer, as well as the patient’s overall health and age. Options include:
-
Active surveillance: Monitoring the cancer closely without immediate treatment, often used for slow-growing cancers in elderly patients.
-
Surgery (Radical prostatectomy): Removal of the prostate gland.
-
Radiotherapy: External beam radiotherapy or brachytherapy (implanting radioactive seeds into the prostate).
-
Hormone therapy: Androgen deprivation therapy (ADT) or anti-androgens to lower testosterone, which fuels prostate cancer growth.
-
Chemotherapy: Used for advanced or metastatic prostate cancer, particularly if hormone therapy is no longer effective.
-
Targeted therapy: Drugs like abiraterone and enzalutamide target specific cancer cell pathways, especially in metastatic castration-resistant prostate cancer (CRPC).
Q: How is localized prostate cancer treated?
A: Treatment for localized prostate cancer depends on risk factors:
-
Low-risk disease: Active surveillance is often the first choice. Surgery or radiotherapy is less common.
-
Intermediate-risk disease: Treatment options include active surveillance, radical prostatectomy, or radiotherapy, sometimes combined with androgen deprivation therapy.
-
High-risk disease: Patients may undergo radical prostatectomy with pelvic lymphadenectomy or external beam radiotherapy combined with neoadjuvant and concurrent androgen deprivation therapy.
Q: How is advanced or metastatic prostate cancer treated?
A: Treatment for metastatic prostate cancer typically involves:
-
Androgen deprivation therapy (ADT): To reduce testosterone levels, which fuel cancer growth.
-
Chemotherapy: Drugs like docetaxel are used when hormone therapy is no longer effective.
-
Targeted therapies: Drugs such as enzalutamide, apalutamide, and abiraterone are used for castration-resistant prostate cancer (CRPC).
-
Radium-223: A radioactive substance that targets bone metastases.
-
PSMA-targeted therapies: Lutetium-177-PSMA is a radiotherapy option that targets prostate cancer cells with PSMA expression.
Q: What are the side effects of prostate cancer treatments?
A: The side effects depend on the treatment method but may include:
-
Surgical side effects: Incontinence, erectile dysfunction, and changes in sexual function.
-
Radiation side effects: Fatigue, urinary problems, and bowel issues.
-
Hormone therapy: Hot flashes, fatigue, reduced libido, and osteoporosis.
-
Chemotherapy: Nausea, fatigue, hair loss, and increased risk of infections.
-
Support and counseling can help manage these side effects.
​
Q: How often will I need follow-up care after treatment for prostate cancer?
A: Follow-up care typically includes:
-
Regular PSA blood tests to monitor for recurrence.
-
Imaging tests (such as CT or MRI) if there are concerns about cancer spread.
-
Bone density scans for patients on long-term hormone therapy to check for osteoporosis.
The frequency of visits depends on the type and stage of cancer, as well as the specific treatment received.
Q: Can I lower my risk of prostate cancer?
A: While you can’t completely eliminate the risk, you can reduce it by:
Staying physically active and maintaining a healthy weight.
Eating a balanced diet with plenty of fruits, vegetables, and healthy fats.
Limiting red meat and processed foods, which may increase the risk.
Regular check-ups: Discuss screening options with your doctor, especially if you're at higher risk (e.g., family history or age over 50).
​KIDNEY CANCER
Q: What is kidney cancer?
A: Kidney cancer is a type of cancer that begins in the kidneys, which are two bean-shaped organs that filter waste from the blood and produce urine. The most common type of kidney cancer is renal cell carcinoma (RCC), accounting for about 90% of cases. There are other types, such as transitional cell carcinoma and Wilms' tumor (which primarily affects children).
Q: What are the common risk factors for kidney cancer?
A: The exact cause of kidney cancer is not known, but certain factors may increase the risk:
-
Smoking: Smoking is a major risk factor for kidney cancer.
-
Obesity: Being overweight increases the risk.
-
Chronic kidney disease (CKD): People with CKD, especially those who have undergone long-term dialysis, are at higher risk.
-
High blood pressure (hypertension): Uncontrolled high blood pressure is linked to kidney cancer.
-
Family history: A family history of kidney cancer or genetic conditions like von Hippel-Lindau disease can increase risk.
-
Age and gender: Kidney cancer is more common in men and typically affects people over 50.
Q: How do I know if I have kidney cancer?
A: Early-stage kidney cancer often has no symptoms, but as it progresses, the following symptoms may occur:
-
Blood in the urine (hematuria), which may appear as pink, red, or brown urine.
-
Pain in the lower back or side, often on one side.
-
A lump or mass in the abdomen.
-
Unexplained weight loss and fatigue.
-
Loss of appetite.
-
Fever not caused by an infection.
-
Swelling of the ankles or legs.
If you experience any of these symptoms, it's important to seek medical attention for further testing.
​
Q: What tests are used to diagnose kidney cancer?
A: Kidney cancer is typically diagnosed through:
-
Imaging tests:
-
CT scan: Helps detect and stage kidney tumors.
-
MRI scan: Provides detailed images of the kidneys and surrounding tissues.
-
Ultrasound: Often used to detect a mass in the kidney.
-
Biopsy: In some cases, a biopsy may be performed to remove a tissue sample from the kidney for analysis.
-
Blood tests: To check kidney function and overall health.
-
Urine tests: To look for blood or abnormal cells in the urine.
Q: How is kidney cancer staged?
A: Kidney cancer is staged based on the size of the tumor and whether it has spread to nearby tissues or other parts of the body. The stages are:
-
Stage I: The tumor is confined to the kidney and is small.
-
Stage II: The tumor is larger but still confined to the kidney.
-
Stage III: The tumor has spread to nearby lymph nodes or blood vessels.
-
Stage IV: The cancer has spread to distant organs, such as the lungs or bones.
Staging helps determine the treatment approach.
​
Q: What are the treatment options for kidney cancer?
A: Treatment for kidney cancer depends on the stage, size of the tumor, and the patient’s overall health. Common treatments include:
-
Surgery:
-
Partial nephrectomy: Removal of the tumor and part of the kidney.
-
Radical nephrectomy: Removal of the entire kidney.
-
Ablation therapies:
-
Radiofrequency ablation (RFA) or cryoablation may be used for small tumors or in patients who are not candidates for surgery.
-
Targeted therapy: These drugs target cancer cells by blocking the signals that allow them to grow and divide. Common drugs include sunitinib, pazopanib, and axitinib.
-
Immunotherapy: This uses the body’s immune system to fight cancer. Drugs like nivolumab and pembrolizumab help boost immune responses against cancer cells.
-
Chemotherapy: Chemotherapy is rarely used for kidney cancer, as it is not very effective for most types of RCC.
-
Radiotherapy: Radiation therapy may be used to treat kidney cancer that has spread to other areas, like the bones or lungs.
​
Q: How is immunotherapy used in kidney cancer treatment?
A: Immunotherapy has become an important treatment option for advanced kidney cancer. These drugs work by stimulating the body’s immune system to target and destroy cancer cells. Some commonly used immunotherapies include:
-
Checkpoint inhibitors: Drugs like nivolumab (Opdivo) and pembrolizumab (Keytruda) help the immune system recognize and attack cancer cells.
-
Cytokine therapy: Interleukin-2 (IL-2) and interferon-alpha were among the first immunotherapy treatments used for advanced kidney cancer, though they are now less common due to side effects.
​
Q: What are the side effects of kidney cancer treatments?
A: The side effects of kidney cancer treatments can vary based on the type of treatment:
-
Surgery: Risk of bleeding, infection, and kidney damage.
-
Targeted therapy: Side effects may include fatigue, diarrhea, high blood pressure, and liver problems.
-
Immunotherapy: Common side effects include fatigue, rash, fever, and inflammation in various organs.
-
Radiation therapy: May cause fatigue, skin irritation, and nausea.
Your doctor will provide guidance on managing side effects and maintaining quality of life during treatment.
Q: What is the outlook for someone with kidney cancer?
A: The prognosis for kidney cancer depends on several factors, including the stage at diagnosis and the patient’s overall health.
-
Early-stage kidney cancer (Stage I) has a good prognosis, with a high chance of successful treatment and long-term survival.
-
Advanced stages (Stages III and IV) may require more aggressive treatment, but immunotherapy and targeted therapies have shown to improve survival rates in these cases.
The survival rate is higher for patients with localized tumors that have not spread to distant organs.
Q: Can kidney cancer be prevented?
A: While there is no guaranteed way to prevent kidney cancer, certain lifestyle changes may reduce your risk:
-
Quit smoking: Smoking is a major risk factor, so stopping can significantly lower your risk.
-
Maintain a healthy weight: Avoid obesity by eating a balanced diet and exercising regularly.
-
Manage blood pressure: Keeping hypertension under control can help reduce your risk.
-
Stay hydrated: Drink plenty of fluids to help maintain kidney function.
Q: How often should I follow up after treatment for kidney cancer?
A: Follow-up care typically involves regular appointments for monitoring kidney function and checking for signs of recurrence. This may include:
-
Imaging tests (CT or MRI scans) to monitor for any new tumors.
-
Blood tests to monitor kidney function and general health.
-
Urine tests to check for abnormalities.
Follow-up frequency depends on the stage and type of treatment, but it is typically every 3-6 months for the first 2-3 years after treatment.
​